|
|
|
Volumn 26, Issue 5 SUPPL. 15, 1999, Pages 55-61
|
|
Strategies to eradicate minimal residual disease in small cell lung cancer: High-dose chemotherapy with autologous bone marrow transplantation, matrix metalloproteinase inhibitors, and BEC2 plus BCG vaccination
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 [4,4 (CHLOROPHENYL)PHENYL] 4 OXO (PHENYLTHIOMETHYL)BUTANOIC ACID;
ANTINEOPLASTIC AGENT;
BATIMASTAT;
BCG VACCINE;
CGS 27023A;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ETOPOSIDE;
MARIMASTAT;
MATRIX METALLOPROTEINASE INHIBITOR;
MELPHALAN;
METHOTREXATE;
MONOCLONAL ANTIBODY;
PRINOMASTAT;
UNCLASSIFIED DRUG;
VINCRISTINE;
ARTHRALGIA;
ARTICLE;
AUTOLOGOUS BONE MARROW TRANSPLANTATION;
CANCER IMMUNOTHERAPY;
CANCER RECURRENCE;
DRUG EFFICACY;
DRUG MEGADOSE;
HUMAN;
LUNG SMALL CELL CANCER;
MULTIMODALITY CANCER THERAPY;
MYALGIA;
PRIORITY JOURNAL;
RASH;
THROMBOCYTOPENIA;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BCG VACCINE;
BONE MARROW TRANSPLANTATION;
CARCINOMA, SMALL CELL;
CLINICAL TRIALS;
ENZYME INHIBITORS;
GANGLIOSIDES;
HUMANS;
LUNG NEOPLASMS;
MATRIX METALLOPROTEINASES;
NEOPLASM, RESIDUAL;
|
|
EID: 0032731305
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (16)
|
|
References (55)
|
